MyFinsight
Home
Blog
About
TENAX THERAPEUTICS, INC. (TENX)
TENAX THERAPEUTICS, INC. (TENX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the exercise of wa...
Stock-based compensation
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Net loss
-33,519
-15,540
-15,804
-21,255
Interest on debt instrument
-
0
0
0
Stock-based compensation
6,168
4,790
5,622
8,751
Prepaid expenses and other current assets
-2,975
3,221
3,046
-1,440
Accounts payable
754
432
5,047
-2,595
Accrued liabilities
163
124
-974
429
Net cash used in operating activities
-23,459
-13,415
-9,155
-13,230
Net cash provided by investing activities
-
-
0
0
Proceeds from issuance of warrants and pre-funded warrants, net of issuance costs
0
0
0
23,216
Proceeds from the exercise of warrants
-
15,298
-
-
Payments on short-term note
-
0
0
0
Proceeds from the exercise of options
30
-
-
-
Proceeds from the exercise of warrants and pre-funded warrants
40,153
-
3,062
625
Net cash provided by financing activities
43,870
11,611
3,062
23,841
Net change in cash and cash equivalents
20,411
-1,804
-6,093
10,611
Cash and cash equivalents, beginning of period
97,565
99,369
94,851
-
Cash and cash equivalents, end of period
117,976
97,565
99,369
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
exercise of warrants and...
$40,153K
(6324.48%↑ Y/Y)
something is missing
$3,687K
Proceeds from the
exercise of options
$30K
Net cash provided by
financing activities
$43,870K
(84.01%↑ Y/Y)
Net change in cash
and cash...
$20,411K
(92.36%↑ Y/Y)
Canceled cashflow
$23,459K
Stock-based compensation
$6,168K
(-29.52%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,975K
(-106.60%↓ Y/Y)
Accounts payable
$754K
(129.06%↑ Y/Y)
Accrued liabilities
$163K
(-62.00%↓ Y/Y)
Net cash used in
operating activities
-$23,459K
(-77.32%↓ Y/Y)
Canceled cashflow
$10,060K
Net loss
-$33,519K
(-57.70%↓ Y/Y)
Buy us a coffee